Handling missing data in clinical research

被引:103
|
作者
Heymans, Martijn W. [1 ]
Twisk, Jos W. R. [1 ,2 ]
机构
[1] Amsterdam UMC, Dept Epidemiol & Data Sci, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Epidemiol & Data Sci, De Boelelaan 1089a, NL-1081 HV Amsterdam, Netherlands
关键词
MULTIPLE IMPUTATION; VALUES;
D O I
10.1016/j.jclinepi.2022.08.016
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Because missing data are present in almost every study, it is important to handle missing data properly. First of all, the missing data mechanism should be considered. Missing data can be either completely at random (MCAR), at random (MAR), or not at random (MNAR). When missing data are MCAR, a complete case analysis can be valid. Also when missing data are MAR, in some situations a complete case analysis leads to valid results. However, in most situations, missing data imputation should be used. Regarding imputation methods, it is highly advised to use multiple imputations because multiple imputations lead to valid estimates including the uncertainty about the imputed values. When missing data are MNAR, also multiple imputations do not lead to valid results. A complication hereby is that it not possible to distinguish whether missing data are MAR or MNAR. Finally, it should be realized that preventing to have missing data is always better than the treatment of missing data. (c) 2022 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:185 / 188
页数:4
相关论文
共 50 条
  • [21] Handling missing data - A commonly encountered problem in quantitative research
    Duffy, Mary E.
    CLINICAL NURSE SPECIALIST, 2006, 20 (06) : 273 - 276
  • [22] A cautionary note on the use of the missing indicator method for handling missing data in prediction research
    van Smeden, Maarten
    Groenwold, Rolf H. H.
    Moons, Karel GM.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020, 125 : 188 - 190
  • [23] A review of the handling of missing longitudinal outcome data in clinical trials
    Matthew Powney
    Paula Williamson
    Jamie Kirkham
    Ruwanthi Kolamunnage-Dona
    Trials, 15
  • [24] Handling missing data issues in clinical trials for rheumatic diseases
    Wong, Weng Kee
    Boscardin, W. J.
    Postlethwaite, A. E.
    Furst, D. E.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (01) : 1 - 9
  • [25] A review of the handling of missing longitudinal outcome data in clinical trials
    Powney, Matthew
    Williamson, Paula
    Kirkham, Jamie
    Kolamunnage-Dona, Ruwanthi
    TRIALS, 2014, 15
  • [26] Commentary: Indefensible Methods of Handling Missing Data in Clinical Trials
    Arndt, Stephan
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (12) : 1997 - 1998
  • [27] AN OVERVIEW OF PRACTICAL APPROACHES FOR HANDLING MISSING DATA IN CLINICAL TRIALS
    DeSouza, Cynthia M.
    Legedza, Anna T. R.
    Sankoh, Abdul J.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 1055 - 1073
  • [28] MISSING DATA HANDLING METHODS IN MEDICAL DEVICE CLINICAL TRIALS
    Yan, Xu
    Lee, Shiowjen
    Li, Ning
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 1085 - 1098
  • [29] PROPOSAL FOR HANDLING MISSING DATA
    GLEASON, TC
    STAELIN, R
    PSYCHOMETRIKA, 1975, 40 (02) : 229 - 252
  • [30] Conservative handling of missing data
    Berger, Vance W.
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (03) : 460 - 460